Sinclair Offers to Buy Remaining EW Scripps Shares at $7.00 Each
Sinclair proposes to acquire all EW Scripps shares it doesn’t already own for $7.00 per share, offering cash and stock options and a 200% premium to recent trading levels.
Sinclair proposes to acquire all EW Scripps shares it doesn’t already own for $7.00 per share, offering cash and stock options and a 200% premium to recent trading levels.
Evercore ISI initiates coverage of Beam Therapeutics (BEAM) with an Outperform rating and $35 price target, citing promising early data for BEAM-302 in treating AATD and highlighting key data expected in Q1 2026.
Barrick Mining reaches settlement with Mali government, ending disputes over Loulo-Gounkoto gold mines. All charges dropped, employees released, operational control restored.
Broadcom gains as Google's acclaimed Gemini 3 AI model showcases custom chip potential, potentially challenging Nvidia's GPU dominance in AI infrastructure.
Dating app Grindr ends take-private negotiations with major shareholders Ray Zage and James Lu, citing unclear financing for the $18/share deal valued at $3.46 billion.
Bayer's asundexian succeeds in Phase 3 stroke prevention trial, becoming first FXIa inhibitor to show positive results and potentially opening door for safer blood clot medications.